Technologies

Life Sciences & Biotechnology

Title:

MiRNA based early diagnostic model for prostate cancer

Area:

Life Sciences & Biotechnology

Focus Area:

Smart device, Digital Health

Status:

Early stage Validation

Social Benefits:

Using miRNA expression patterns we will construct a machine learning algorithm for a panel of miRNAs and thus create a PCa early diagnosis model specific to the Indian population setting. Early diagnosis of PCa will not only promote healthy life changes through creating self-health awareness but also will save patient from undergoing more invasive method of PCa diagnosis such as DRE, Biopy etc. Early diagnosis will also cut down the delay time in access to the hospital where more robust preventive and treatment strategies could be adopted to reduce PCa associated morbidity and mortality.

Developing Agency:

Mirnow Llp, Uttar Pradesh

Technology Readiness Index:

TRL 6

Source Title:

Data sourced from Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT)

Brief Description

Description :

This approach will be the first of its kind where links of known risk-associated miRNAs will be explored in the large cohort of the Indian population.

Related Technologies